Pregabalin and gabapentin inhibit substance P-induced NF-κB activation in neuroblastoma and glioma cells

Journal of Cellular Biochemistry

Volumn 105, Issue 2, 2008, Pages 414-423

  Park, Seyeon ^a   Eun, Sook Ahn ^a   Dong, Woo Han ^b   Jong, Hwa Lee ^b   Kyung, Tae Min ^b   Kim, Hyunkyung ^c   Hong, Yong Woo ^b  

^a Dongduk Women's University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Hansung Science High School   (South Korea)

Author keywords

Gabapentin; Glioma; Neuroblastoma; NF KB; Pregabalin; Substance P

Indexed keywords

GABAPENTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PREGABALIN; SUBSTANCE P; SYNAPTOTAGMIN I;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL ACTIVATION; CONTROLLED STUDY; DRUG INHIBITION; GEL MOBILITY SHIFT ASSAY; GLIOMA; HUMAN; HUMAN CELL; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SPINAL GANGLION;

AMINES; ANIMALS; CELL LINE, TUMOR; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; GANGLIA, SPINAL; GLIOMA; HUMANS; INFLAMMATION; NEUROBLASTOMA; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SUBSTANCE P;

RATTUS;

EID: 54849437914     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21837     Document Type: Article

References (50)

1. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E. 1998. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280:1831-1836.
2. Bahrami G, Mohammadi B. 2006. Sensitive microanalysis of gabapentin by high-performance liquid chromatography in human serum using precolumn derivatization with 4-chloro-7-nitrobenzofurazan: Application to a bioequivalence study. J Chromatogr B 837:24-28.
3. Barker R. 1991. Substance P and neurodegenerative disorders. A. speculative review. Neuropeptides 20:73-78.
4. Beattie DT, Beresford IJ, Connor HE, Marshall FH, Hawcock AB, Hagan RM, Bowers J, Birch PJ, Ward P. 1995. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist. Br J Pharmacol 116:3149-3157.
5. Bordey A, Feltz P, Trouslard J. 1994. Mobilization of intracellular calcium by substance P in a human astrocytoma cell line (U-373 MG). Glia 11:277-283.
6. Brown JT, Randall A. 2005. Gabapentin fails to alter P/Q-type Ca2Rchannel-mediated synaptic transmission in the hippocampus in vitro. Synapse 55:262-269.
7. Bryans JS, Wustrow DJ. 1999. 3-substituted GABA analogs with central nervous system activity: a review. Med Res Rev 19:149-177.
8. Chen SR, Xu Z, Pan HL. 2001. Stereospecific effect of pregabalin on ectopic afferent discharges and neuropathic pain induced by sciatic nerve ligation in rats. Anesthesiology 95:1473-1479.
9. Dirks J, Fredensborg BB, Christensen D, Fomsgaard JS, Flyger H, Dahl JB. 2002. A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology 97:560-564.
10. Dubner R, Ruda MA. 1992. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci 15:96-103.
11. Fehrenbacher JC, Taylor CP, Vasko MR. 2003. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 105:133-141.
12. Field MJ, Holloman EF, McCleary S, Hughes J, Singh L. 1997. Evaluation of gabapentin and S-(R)-3-isobutylgaba in a rat model of postoperative pain. J Pharmacol Exp Ther 282:1242-1246.
13. Finco TS, Beg AA, Baldwin AS Jr. 1994. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc Natl Acad Sci U S A 91:11884-11888.
14. Ghosh S, Karin M. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109:81-96.
15. Gitter BD, Regoli D, Howbert JJ, Glasebrook AL, Waters DC. 1994. Interleukin-6 secretion from human astrocytoma cells induced by substance P. J Neuroimmunol 51:101-108.
16. Graeme JS. 2006. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 6:108-113.
17. Han SS, Kim K, Hahm ER, Lee SJ, Surh YJ, Park HK, Kim WS, Jung CW, Lee MH, Park K, Yang JH, Yoon SS, Riordan NH, Riordan HD, Kimler BF, Park CH, Lee JH, Park S. 2004. L-Ascorbic acid represses constitutive activation of NFkappaB and COX-2 expression in human acute myeloid leukemia, HL-60. J Cell Biochem 93:257-270.
18. Houghton AK, Lu Y, Westlund KN. 1998. S-(R)-3-isobutylgaba and its stereoisomer reduces the amount of inflammation and hyperalgesia in an acute arthritis model in the rat. J Pharmacol Exp Ther 285:533-538.
19. Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J, Fontana DJ. 1997. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 324:153-160.
20. Jalalizadeh H, Souri E, Tehrani MB, Jahangiri A. 2007. Validated HPLC method for the determination of gabapentin in human plasma using pre-column derivatization with 1-fluoro-2,4-dinitrobenzene and its application to a pharmacokinetic study. J Chromatogr B 854:43-47.
21. Kavelaars A, Broeke D, Jeurissen F, Kardux J, Meijer A, Franklin R, Gelfand EW, Heijnen CJ. 1994. Activation of human monocytes via a non-neurokinin substance P receptor that is coupled to Gi protein, calcium, phospholipase D, MAP kinase, and IL-6 production. J Immunol 153:3691-3699.
22. Lieb K, Fiebich BL, Berger M, Bauer J, Schulze-Osthoff K. 1997. The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol 159:4952-4958.
23. Macdonald SG, Boyd ND. 1989. Regulation of substance P receptor affinity by guanine nucleotide-binding proteins. J Neurochem 53:264-272.
24. Mahon TM, O'Neill LA. 1995. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit. J Biol Chem 270:28557-28564.
25. Maneuf YP, Gonzalez MI, Sutton KS, Chung FZ, Pinnock RD, Lee K. 2003. Cellular and molecular action of the putative GABA-mimetic, gabapentin. Cell Mol Life Sci 60:742-750.
26. Maneuf YP, McKnight AT. 2001. Block by gabapentin of the facilitation of glutamate release from rat trigeminal nucleus following activation of protein kinase C or adenylyl cyclase. Br J Pharmacol 134:237-240.
27. Martin FC, Charles AC, Sanderson MJ, Merrill JE. 1992. Substance P stimulates IL-1 production by astrocytes via intracellular calcium. Brain Res 599:13-18.
28. McGillis JP, Mitsuhashi M, Payan DG. 1990. Immunomodulation by tachykinin neuropeptides. Ann N Y Acad Sci 594:85-94.
29. Moore KA, Baba H, Woolf CJ. 2002. Gabapentin - actions on adult superficial dorsal horn neurons. Neuropharmacology 43:1077-1081.
30. Mrak RE, Sheng JG, Griffin WS. 1995. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol 26:816-823.
31. Nanayama T, Kuraishi Y, Ohno H, Satoh M. 1989. Capsaicin-induced release of calcitonin gene-related peptide from dorsal horn slices is enhanced in adjuvant arthritic rats. Neurosci Res 6:569-572.
32. Oku R, Satoh M, Takagi H. 1987. Release of substance P from the spinal dorsal horn is enhanced in polyarthritic rats. Neurosci Lett 74:315-319.
33. Partridge BJ, Chaplan SR, Sakamoto E, Yaksh TL. 1998. Characterization of the effects of gabapentin and 3-isobutyl-gamma-aminobutyric acid on substance P-induced thermal hyperalgesia. Anesthesiology 88:196-205.
34. Patel MK, Gonzalez MI, Bramwell S, Pinnock RD, Lee K. 2000. Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord. Br J Pharmacol 130:1731-1734.
35. Paveliev M, Airaksinen MS, Saarma M. 2004. GDNF family ligands activate multiple events during axonal growth in mature sensory neurons. Mol Cell Neurosci 25:453-459.
36. Regoli D, Drapeau G, Dion S, D'Orleans-Juste P. 1989. Receptors for substance P and related neurokinins. Pharmacology 38:1-15.
37. Rosenberg JM, Harrell C, Ristic H, Werner RA, de Rosayro AM. 1997. The effect of gabapentin on neuropathic pain. Clin J Pain 13:251-255.
38. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. 1998. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280:1837-1842.
39. Ryu PD, Gerber G, Murase K, Randic M. 1988. Calcitonin gene-related peptide enhances calcium current of rat dorsal root ganglion neurons and spinal excitatory synaptic transmission. Neurosci Lett 89:305-312.
40. Serpell MG, Neuropathic Pain Study Group. 2002. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain 99:557-566.
41. Shishodia S, Koul D, Aggarwal BB. 2004. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J. Immunol 173:2011-2022.
42. Southall MD, Michael RL, Vasko MR. 1998. Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slices. Pain 78:39-48.
43. Stanfa LC, Singh L, Williams RG, Dickenson AH. 1997. Gabapentin, ineffective in normal rats, markedly reduces C-fibre evoked responses after inflammation. Neuroreport 8:587-590.
44. Takasaki I, Andoh T, Nojima H, Shiraki K, Kuraishi Y. 2001. Gabapentin antinociception in mice with acute herpetic pain induced by herpes simplex virus infection. J Pharmacol Exp Ther 296:270-275.
45. Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty DF, Brown JP, Dooley DJ, Boden P, Singh L. 1998. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 29:233-249.
46. Thanos D, Maniatis T. 1995. NF-κB: A lesson in family values. Cell 80:529-532.
47. van Ginkel FW, Pascual DW. 1996. Recognition of neurokinin 1 receptor (NK1-R): an antibody to a peptide sequence from the third extracellular region binds to brain NK1-R. J Neuroimmunol 67:49-58.
48. Werner MU, Perkins FM, Holte K, Pedersen JL, Kehlet H. 2001. Effects of gabapentin in acute inflammatory pain in humans. Reg Anesth Pain Med 26:322-328.
49. Xiao WH, Bennett GJ. 1996. Gabapentin has an antinociceptive effect mediated via a spinal site of action in a rat model of painful peripheral neuropathy. Analgesia 2:267.
50. Yashpal K, Wright DM, Henry JL. 1982. Substance P reduces tailflick latency: implications for chronic pain syndromes. Pain 14:155-167.